Boston Scientific (BSX) Total Liabilities (2009 - 2026)
Boston Scientific (BSX) posted quarterly Total Liabilities of $45.2 billion for Q2 2026, up 8.8% year-over-year from $41.6 billion in Q2 2025, and up 1.95% on a QoQ basis from $44.4 billion in Q1 2026.
Boston Scientific (BSX) Total Liabilities (2009 - 2026) Analysis & Trends
Boston Scientific has reported Total Liabilities for 18 years, with the latest figure at $45.2 billion in Q2 2026.
- Total Liabilities for Q2 2026 came in at $45.2 billion, up 8.8% year-over-year; the trailing twelve-month figure through Jun 2026 was $45.2 billion (up 8.8% YoY), and the FY2025 annual result was $43.7 billion, up 10.86% from the prior year.
- Total Liabilities advanced to $45.2 billion in Q2 2026, from $44.4 billion in the prior quarter.
- Over five years, Total Liabilities peaked at $45.2 billion in Q2 2026 and troughed at $31.9 billion in Q3 2022.
- A 5-year average of $37.4 billion and a median of $36.9 billion in 2024 frame the typical range for Total Liabilities.
- The widest annual swing landed in 2022, when Total Liabilities advanced 0.22%; it then grew 12.16% in 2025.
- A 5-year view of Total Liabilities shows it stood at $32.5 billion in 2022, then advanced by 8.21% to $35.1 billion in 2023, then increased by 12.12% to $39.4 billion in 2024, then increased by 10.86% to $43.7 billion in 2025, then climbed by 3.53% to $45.2 billion in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $45.2 billion in Q2 2026, $44.4 billion in Q1 2026, and $43.7 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 10.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.22 Bn |
| Mar 31, 2026 | 44.35 Bn |
| Dec 31, 2025 | 43.67 Bn |
| Sep 30, 2025 | 42.71 Bn |
| Jun 30, 2025 | 41.56 Bn |
| Mar 31, 2025 | 40.14 Bn |
| Dec 31, 2024 | 39.40 Bn |
| Sep 30, 2024 | 38.08 Bn |
| Jun 30, 2024 | 37.11 Bn |
| Mar 31, 2024 | 36.67 Bn |
| Dec 31, 2023 | 35.14 Bn |
| Sep 30, 2023 | 34.04 Bn |
| Jun 30, 2023 | 33.60 Bn |
| Mar 31, 2023 | 32.89 Bn |
| Dec 31, 2022 | 32.47 Bn |
| Sep 30, 2022 | 31.95 Bn |
| Jun 30, 2022 | 32.19 Bn |
| Mar 31, 2022 | 32.34 Bn |
| Dec 31, 2021 | 32.23 Bn |
| Sep 30, 2021 | 31.88 Bn |